Clinical and Biological Anti-aging Efficacy of a Cosmetic Cream
NCT ID: NCT05895591
Last Updated: 2023-06-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
33 participants
INTERVENTIONAL
2021-10-12
2021-12-14
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* on skin network after 56 days of daily application
* on biological parameters linked to cellular communication involved in senescence
* on sebum composition (metagenomics and metabolomics analysis)
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Biological Anti-aging Efficacy of a Cosmetic Night Cream
NCT06433323
Evaluation of the Anti-aging Efficacy of a Novel Skin Health Product
NCT05300984
Efficacy and Safety of Skin Care Product in Aging Facial Skin
NCT04015063
In-use Tolerance and Efficacy Study Under Dermatological and Ophthalmological Controls - Face Cream, RV4983A - LA3365
NCT07208227
Anti-Wrinkle Efficacy Study of an Eye-Cream
NCT05805735
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
4 visits are planned:
* Visit 1 - Inclusion (D1)
* Visit 2 - Follow-up visit (D29), a window of +72 hours is allowed for this evaluation,
* Visit 3 - End of the application period (D57), a window of +72 hours is allowed for this evaluation
* Visit 4 - Follow-up visit (D7 post-biopsies +/- 24h)
For a subject completing the study, the theoretical investigational product application will be 56 consecutive days up to 59 days maximum.
The study duration for each subject will be 67 days maximum.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Treated Group
all subjects will apply the study product
Anti-aging cosmetic care product
* frequency of application: Once a day (in the morning)
* modalities of application: Apply the cream on face (according to normal conditions of use) and on treated forearm, massage until complete penetration
* area: The whole face, neck, neckline and one randomized forearm (external photo-exposed area) the other forearm is untreated
* duration of investigational product application: 56 days (a window of + 72 hours is allowed)
* quantity: 2 pressures of product for the whole face, neck and neckline and 1 pressure of product for the treated forearm
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Anti-aging cosmetic care product
* frequency of application: Once a day (in the morning)
* modalities of application: Apply the cream on face (according to normal conditions of use) and on treated forearm, massage until complete penetration
* area: The whole face, neck, neckline and one randomized forearm (external photo-exposed area) the other forearm is untreated
* duration of investigational product application: 56 days (a window of + 72 hours is allowed)
* quantity: 2 pressures of product for the whole face, neck and neckline and 1 pressure of product for the treated forearm
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* face skin type: combination to normal skin
* presenting wrinkles and/or finelines on the whole face
* displaying saggy skin on the face (loss of firmness)
* presenting a lack of skin radiance, dull complexion and an inhomogeneous skin on the face
Exclusion Criteria
* having had any surgery, chemical or significant invasive dermo-treatment on the experimental area considered by the Investigator liable to interfere with the study data
* having undergone techniques with aesthetic aim on study areas (chemical peel, mechanical dermabrasion, laser, pulsed flash lamp etc.) or having made injections of anti-wrinkle products (collagen, hyaluronic acid, botulinic toxin etc.)
* having applied products with an anti-aging action (Retinoic acid, retinol, retinaldehyde, A.H.A. etc.)
35 Years
55 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pierre Fabre Dermo Cosmetique
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Spincontrol
Tours, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RV4981A20210184
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.